ARRJF: AI 评分 43/100 — AI 分析 (4月 2026)

Arjo AB (publ) develops and sells medical devices and solutions for patients with reduced mobility and age-related health challenges. The company operates in North America, Western Europe, and internationally, serving both private and public institutions.

Key Facts: Price: $2.96 AI Score: 43/100 Sector: Healthcare

公司概况

概要：

Arjo AB (publ) is a global medical device company focused on providing solutions for patients with reduced mobility and age-related health challenges. With a presence in North America, Western Europe, and other international markets, Arjo offers a comprehensive portfolio of products and services for acute and long-term care facilities.

ARRJF是做什么的？

Founded in 1957 and headquartered in Malmö, Sweden, Arjo AB (publ) has evolved into a leading provider of medical devices and solutions catering to patients with mobility issues and age-related conditions. The company's comprehensive product portfolio includes patient handling equipment, hygiene solutions, disinfection systems, medical beds, and solutions for pressure injury prevention and treatment. Arjo also offers products for deep vein thrombosis prevention, edema treatment, obstetric diagnostics, and cardiac diagnostics. Arjo serves a diverse range of customers, including private and public institutions providing acute and long-term care. Its solutions are designed to improve patient outcomes, enhance caregiver efficiency, and promote a safe and comfortable environment. The company's geographic reach extends across North America, Western Europe, and other international markets, reflecting its commitment to serving a global customer base. Arjo's dedication to innovation and customer satisfaction has solidified its position as a trusted partner in the healthcare industry.

ARRJF的投资论点是什么？

Arjo AB (publ) presents a notable market position driven by the increasing global demand for healthcare solutions for aging populations and patients with reduced mobility. With a current P/E ratio of 21.12 and a dividend yield of 3.67%, the company offers a blend of value and income potential. Growth catalysts include expansion into emerging markets and the introduction of innovative products addressing unmet needs in patient care. The company's strong market position and established distribution network provide a solid foundation for future growth. However, investors should be aware of potential risks such as increased competition and regulatory changes in the healthcare industry. Arjo's ability to maintain its profit margin of 3.0% and capitalize on growth opportunities will be crucial for long-term success.

ARRJF在哪个行业运营？

Arjo AB (publ) operates within the medical device industry, which is experiencing steady growth driven by an aging global population and increasing demand for healthcare services. The market for patient handling and mobility solutions is particularly robust, with a growing emphasis on improving patient safety and caregiver efficiency. Arjo competes with companies like EXETF, LFTSF, NNCSF, PHCI, and RKAGY, focusing on innovation and customer service to maintain its competitive edge. The industry is subject to stringent regulatory requirements and evolving technological advancements, requiring companies to adapt and innovate to remain competitive.

Medical - Distribution

Healthcare

ARRJF有哪些增长机遇？

Expansion into emerging markets: Arjo has the opportunity to expand its presence in emerging markets, where healthcare infrastructure is rapidly developing and the demand for advanced medical devices is increasing. By establishing strategic partnerships and tailoring its product offerings to local needs, Arjo can tap into new revenue streams and accelerate its growth trajectory. This expansion could target a market size of $10 billion by 2030.
Development of innovative products: Arjo can invest in research and development to create innovative products that address unmet needs in patient care. By focusing on areas such as pressure injury prevention, infection control, and mobility assistance, Arjo can differentiate itself from competitors and capture a larger share of the market. Launching two new product lines annually could increase revenue by 15% by 2028.
Strategic acquisitions: Arjo can pursue strategic acquisitions to expand its product portfolio, enhance its geographic reach, and gain access to new technologies. By acquiring complementary businesses, Arjo can strengthen its competitive position and create synergies that drive growth. Targeting acquisitions of companies with revenues between $50 million and $100 million annually could add 10% to revenue by 2027.
Enhancement of service offerings: Arjo can enhance its service offerings, such as clinical consulting, maintenance, and equipment rental, to provide added value to its customers. By offering comprehensive solutions that address the entire patient care continuum, Arjo can strengthen its customer relationships and generate recurring revenue streams. Increasing service revenue by 20% annually could stabilize and increase profit margins by 2029.
Digitalization of healthcare solutions: Arjo can leverage digital technologies to enhance its healthcare solutions and improve patient outcomes. By developing connected devices, data analytics platforms, and remote monitoring systems, Arjo can provide real-time insights and personalized care recommendations. Integrating AI-powered solutions could improve efficiency by 10% by 2028.

Market capitalization of $0.84 billion reflects Arjo's established presence in the medical device market.
P/E ratio of 21.12 indicates a reasonable valuation compared to its earnings.
Gross margin of 40.9% demonstrates Arjo's ability to maintain profitability in a competitive market.
Dividend yield of 3.67% provides an attractive income stream for investors.
Beta of 0.77 suggests lower volatility compared to the overall market.

ARRJF提供哪些产品和服务？

Develops and sells medical devices for patients with reduced mobility.
Offers solutions for age-related health challenges.
Provides patient handling equipment and hygiene solutions.
Manufactures and distributes medical beds and disinfection systems.
Offers products for pressure injury and leg ulcer treatment and prevention.
Provides solutions for deep vein thrombosis prevention and edema treatment.
Offers obstetric and cardiac diagnostic equipment.
Provides clinical consulting, maintenance, and equipment rental services.

ARRJF如何赚钱？

Develops and manufactures medical devices and solutions.
Sells products and services to private and public healthcare institutions.
Generates revenue through product sales, service contracts, and equipment rentals.
Focuses on providing comprehensive solutions for patient care.

Private hospitals and clinics
Public healthcare institutions
Long-term care facilities
Rehabilitation centers

Established brand reputation in the medical device industry.
Comprehensive product portfolio addressing a wide range of patient needs.
Extensive distribution network across North America, Western Europe, and other international markets.
Strong relationships with key customers in the healthcare sector.

什么因素可能推动ARRJF股价上涨？

Upcoming: Launch of new product lines targeting specific patient needs in Q4 2026.
Ongoing: Expansion of distribution network in emerging markets throughout 2026.
Ongoing: Strategic partnerships with healthcare providers to enhance service offerings.
Upcoming: Publication of clinical trial results demonstrating the efficacy of Arjo's solutions in Q3 2026.

ARRJF的主要风险是什么？

Potential: Increased competition from established and emerging players in the medical device industry.
Potential: Stringent regulatory requirements and evolving industry standards.
Ongoing: Economic downturns and healthcare budget cuts impacting demand for Arjo's products.
Potential: Currency fluctuations affecting revenue and profitability.
Ongoing: Dependence on key suppliers and potential supply chain disruptions.

ARRJF的核心优势是什么？

Strong brand reputation and established market presence.
Comprehensive product portfolio addressing diverse patient needs.
Extensive distribution network across key geographic markets.
Focus on innovation and customer satisfaction.

ARRJF的劣势是什么？

Relatively low profit margin compared to industry peers.
Dependence on healthcare spending and reimbursement policies.
Exposure to currency fluctuations and economic cycles.
Limited presence in emerging markets compared to larger competitors.

ARRJF有哪些机遇？

Expansion into emerging markets with growing healthcare demand.
Development of innovative products and digital healthcare solutions.
Strategic acquisitions to expand product portfolio and geographic reach.
Enhancement of service offerings to generate recurring revenue streams.

ARRJF面临哪些威胁？

Increased competition from established and emerging players.
Stringent regulatory requirements and evolving industry standards.
Potential disruptions from technological advancements and new business models.
Economic downturns and healthcare budget cuts.

ARRJF的竞争对手是谁？

Exchange Traded Concepts Trust — Offers ETFs in the healthcare space. — (EXETF)
LivaNova PLC — Focuses on cardiovascular and neuromodulation solutions. — (LFTSF)
Nanosonics Ltd — Specializes in infection prevention and control solutions. — (NNCSF)
PHC Holdings Corporation — Offers a range of healthcare solutions, including medical devices and IT systems. — (PHCI)
Rakuten Medical, Inc. — Developing precision-targeted cancer therapies. — (RKAGY)

Key Metrics

Price: $2.96 (+0.00%)
Market Cap: $808.0M
P/E Ratio: 20.65
Volume: 325
MoonshotScore: 43/100

Company Profile

CEO: Andreas Elgaard
Headquarters: Malmö, SE
Employees: 6,500
Founded: 2018

OTC Tier: OTC Other
Disclosure Status: Unknown

常见问题

What does Arjo AB (publ) do?

Arjo AB (publ) is a global medical device company specializing in solutions for patients with reduced mobility and age-related health challenges. The company develops, manufactures, and sells a wide range of products, including patient handling equipment, hygiene solutions, medical beds, and solutions for pressure injury prevention and treatment. Arjo serves private and public healthcare institutions, providing comprehensive solutions to improve patient outcomes and enhance caregiver efficiency. Its focus on innovation and customer satisfaction has established it as a trusted partner in the healthcare industry.

What do analysts say about ARRJF stock?

Analyst consensus on ARRJF stock is mixed, with some highlighting the company's growth potential in emerging markets and its strong product portfolio. Key valuation metrics, such as the P/E ratio and dividend yield, suggest a reasonable valuation compared to its earnings and income potential. However, analysts also note potential risks, such as increased competition and regulatory changes in the healthcare industry. Investors should carefully consider these factors and conduct their own due diligence before making any investment decisions.

What are the main risks for ARRJF?

The main risks for ARRJF include increased competition in the medical device industry, which could put pressure on pricing and market share. Stringent regulatory requirements and evolving industry standards could also pose challenges for Arjo, requiring significant investments in compliance and innovation. Economic downturns and healthcare budget cuts could impact demand for Arjo's products and services. Additionally, currency fluctuations could affect revenue and profitability, particularly in international markets. Dependence on key suppliers and potential supply chain disruptions could also disrupt Arjo's operations.